The patient's perspective: The effect of levodopa on Parkinson symptoms

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

JAMA Neurol.

Schapira AH, Fox SH, Hauser RA, Jankovic J, Jost WH, Kenney C, Kulisevsky J, Pahwa R, Poewe W, Anand R

doi: 10.1001/jamaneurol.

COMMENTED

Parkinson’s Disease

Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease

N Engl J Med.

Verschuur CVM, Suwijn SR, Boel JA, Post B, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Munts AG, Deuschl G, Lang AE, Dijkgraaf MGW, de Haan RJ, de Bie RMA, LEAP Study Group

doi: 10.1056/NEJMoa1809983.

RECOMMENDED

Parkinson’s Disease

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

Lancet Neurol.

LeWitt PA, Hauser RA, Pahwa R, Isaacson SH, Fernandez HH, Lew M, Saint-Hilaire M, Pourcher E, Lopez-Manzanares L, Waters C, Rudzínska M, Sedkov A, Batycky R, Oh C, SPAN-PD Study Investigators

doi: 10.1016/S1474-4422(18)30405-8.

Aging and Cognitive Functions

Pallidal stimulation in Parkinson's patients with contraindications to subthalamic target: A 3 years follow-up.

Parkinsonism Relat Disord.

Bonenfant J, Drapier S, Houvenaghel JF, Naudet F, Haegelen C, Sauleau P, Vérin M

doi: 10.1016/

Anxiety and Depression

Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease

J Parkinsons Dis.

Cattaneo C, Müller T, Bonizzoni E, Lazzeri G, Kottakis I, Keywood C

doi: 10.3233/JPD-171143.

Parkinson’s Disease

Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial

Lancet Neurol.

van der Kolk NM, de Vries NM, Kessels RPC, Joosten H, Zwinderman AH, Post B, Bloem BR

doi: 10.1016/S1474-4422(19)30285-6.

Aging and Cognitive Functions

Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson's Disease

Parkinsons Dis.

Eichelberger D, Calabrese P, Meyer A, Chaturvedi M, Hatz F, Fuhr P, Gschwandtner U

doi: 10.1155/2017/3659784.

Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease

Mov Disord.

Fox SH, Metman LV, Nutt JG, Brodsky M, Factor SA, Lang AE, Pope LE, Knowles N, Siffert J

doi: 10.1002/mds.26976.

Anxiety and Depression

Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders: A meta-analysis

Brain Behav

von Känel R, Kasper S, Bondolfi G, Holsboer-Trachsler E, Hättenschwiler J, Hatzinger M, Imboden C, Heitlinger E, Seifritz E

doi: 10.1002/brb3.1997

Related content

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

Pallidal stimulation in Parkinson's patients with contraindications to subthalamic target: A 3 years follow-up.

Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease

Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial

Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson's Disease

Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease

Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders: A meta-analysis